1. SYRA will report Q1 2025 financial results on May 8. 2. A conference call will discuss these results at 9:00 a.m. ET. 3. Investors can submit questions prior to the call via email. 4. SYRA focuses on innovative healthcare technology for mental health and access. 5. A repeat of the conference call will be available online after.
Upcoming financial results may create uncertainty, reflecting past examples where earnings reports led to volatility for similar tech stocks.
The upcoming call may draw investor interest, depending on the financial performance revealed.
The immediate effects of earnings reports typically influence stock prices within a quarter.
Conference call will be held on Thursday, May 8, at 9:00 a.m. ET
CARMEL, Ind., May 1, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended March 31, 2025, on Thursday, May 8, 2025, before market open. The Company will host a conference call that same day, May 8, 2025, at 9:00 a.m. ET, to discuss the results.
Interested parties can access the conference call via webcast, available in the investors section of the company's website at https://ir.syrahealth.com/presentations/Q1-2025-earnings-call.
Investors who would like to submit a question to be addressed on the call should email info@syrahealth.com.
A webcast replay will be available in the investors section of the company's website at https://ir.syrahealth.com/presentations/Q1-2025-earnings-call.
Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology products and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit www.syrahealth.com.
For Investor Inquiries:
Corbin Woodhull
Managing Director, Global Advisory
Hayden IR
602-476-1821
info@syrahealth.com
For Media Inquiries:
Christine Drury
Director of Corporate Communications
Syra Health
463-345-5180
media@syrahealth.com
SOURCE Syra Health